Cargando…

Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study

Detalles Bibliográficos
Autores principales: Sun, Yuankai, Wang, Jiajia, Qiu, Yulu, Lin, Shiyu, Wang, Fang, Tan, Wenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945485/
https://www.ncbi.nlm.nih.gov/pubmed/36583925
http://dx.doi.org/10.1097/CM9.0000000000002047
_version_ 1784892151070457856
author Sun, Yuankai
Wang, Jiajia
Qiu, Yulu
Lin, Shiyu
Wang, Fang
Tan, Wenfeng
author_facet Sun, Yuankai
Wang, Jiajia
Qiu, Yulu
Lin, Shiyu
Wang, Fang
Tan, Wenfeng
author_sort Sun, Yuankai
collection PubMed
description
format Online
Article
Text
id pubmed-9945485
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99454852023-02-23 Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study Sun, Yuankai Wang, Jiajia Qiu, Yulu Lin, Shiyu Wang, Fang Tan, Wenfeng Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-11-05 2022-03-08 /pmc/articles/PMC9945485/ /pubmed/36583925 http://dx.doi.org/10.1097/CM9.0000000000002047 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Sun, Yuankai
Wang, Jiajia
Qiu, Yulu
Lin, Shiyu
Wang, Fang
Tan, Wenfeng
Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title_full Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title_fullStr Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title_full_unstemmed Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title_short Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
title_sort real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945485/
https://www.ncbi.nlm.nih.gov/pubmed/36583925
http://dx.doi.org/10.1097/CM9.0000000000002047
work_keys_str_mv AT sunyuankai reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy
AT wangjiajia reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy
AT qiuyulu reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy
AT linshiyu reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy
AT wangfang reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy
AT tanwenfeng reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy